OVERVIEW
An epidemiological or prevalence model estimates the number of patients living with a condition in a defined geography, the proportion who are diagnosed and treated, and the subset eligible for a specific therapy. It is the foundation on which every other health economics model is built.
WHEN TO USE THIS MODEL
Is this the right model for you?
- Sizing the addressable patient population ahead of launch
- Building the denominator for a Budget Impact or Cost of Illness model
- Supporting commercial forecasting and market sizing
- Informing pricing and reimbursement strategy
- Preparing patient advocacy and health policy submissions
WHAT WE DELIVER
What's included
Prevalence and incidence estimates
sourced from published epidemiology, registries, and claims data
Diagnosis funnel
from total prevalence through to diagnosed, treated, and eligible populations
Subgroup analysis
by disease severity, line of therapy, biomarker status, or other clinically relevant criteria
Trend modelling
projected population growth over a 5–10 year horizon
Geographic breakdowns
national, regional, or integrated care system level where data supports
Full technical report with data sources, assumptions, and uncertainty ranges
PRICING
Fee tiers
TIER
FEE
TIMELINE
Single Market
Prevalence and diagnosis funnel, one geography
£6,000–12,000
3–4 weeks
Multi-Market
3–5 geographies with consistent methodology
£18,000–30,000
6–10 weeks
All fees are fixed price. Scope, deliverables, and timeline are agreed before work begins. Additional market adaptations available — contact us for a tailored quote.